title: The role of chemotherapy in the treatment of head and neck cancer.
authors.affiliation: Department of Otolaryngology, Hokkaido University School of Medicine.
authors.forename: Y
authors.initials: Y
authors.lastname: Inuyama
authors.forename: S
authors.initials: S
authors.lastname: Fukuda
authors.forename: Y
authors.initials: Y
authors.lastname: Furuta
authors.forename: K
authors.initials: K
authors.lastname: Yagi
authors.forename: T
authors.initials: T
authors.lastname: Nagahashi
authors.forename: E
authors.initials: E
authors.lastname: Chida
authors.forename: H
authors.initials: H
authors.lastname: Shirato
authors.forename: M
authors.initials: M
authors.lastname: Fujii
authors.forename: J
authors.initials: J
authors.lastname: Kanzaki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000188:drug therapy / Q000401:mortality; D017663:Peplomycin / Q000008:administration & dosage; D015996:Survival Rate; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; C096910:UFT(R) drug; D005641:Tegafur; D017663:Peplomycin; D014498:Uracil; D016190:Carboplatin; D002945:Cisplatin